REQUEST A DEMO
Total
USD $0.00
Search more companies

SGS Pharma Magyarorszag Kft. (Hungary)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: SGS Pharma Magyarorszag Kft. Profile Updated: September 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Hungarian Download a sample report

SGS Pharma Magyarorszag Kft. is a company based in Hungary, with its head office in Budapest. It operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. SGS Pharma Magyarorszag Kft. was incorporated on March 10, 2020. In 2024, the company reported a net sales revenue increase of 564.95%. A growth of 198.89% was recorded in its total assets. The net profit margin of SGS Pharma Magyarorszag Kft. decreased by 35.46% in 2024.

Headquarters
Honved utca 8. 1. emelet 2.
Budapest; Budapest; Postal Code: 1054

Contact Details: Purchase the SGS Pharma Magyarorszag Kft. report to view the information.

Website: http://www.sgslab.eu

Basic Information
Registered Capital:
Purchase the SGS Pharma Magyarorszag Kft. report to view the information.
Financial Auditors:
Purchase the SGS Pharma Magyarorszag Kft. report to view the information.
Incorporation Date:
March 10, 2020
Key Executives
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after SGS Pharma Magyarorszag Kft. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
564.95%
Total operating revenue
566.52%
Operating profit (EBIT)
147.42%
EBITDA
147.39%
Net Profit (Loss) for the Period
164.66%
Total Assets
198.89%
Total Equity
204.28%
Operating Profit Margin (ROS)
-41.84%
Net Profit Margin
-35.46%
Return on Equity (ROE)
-10.05%
Quick Ratio
1.78%
Cash Ratio
0.52%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?